test

Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.

Jardemark K, Marcus MM, Malmerfelt A, Shahid M, Svensson TH. Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission. Psychopharmacology. 2012;221(1):115-31. DOI: 10.1007/s00213-011-2554-3. PubMed PMID: 22068461.

Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Colfax GN, Santos G-M, Das M, Santos DM, Matheson T, Gasper J, et al. Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry. 2011;68(11):1168-75. DOI: 10.1001/archgenpsychiatry.2011.124. PubMed PMID: 22065532; PubMed Central PMCID: PMC3437988.

The Physicians' Competence in Substance Abuse Test (P-CSAT): a multidimensional educational measurement tool for substance abuse training programs.

Harris JM, Sun H. The Physicians' Competence in Substance Abuse Test (P-CSAT): a multidimensional educational measurement tool for substance abuse training programs. Drug Alcohol Dependence. 2012;122(3):236-40. DOI: 10.1016/j.drugalcdep.2011.10.006. PubMed PMID: 22055011; PubMed Central PMCID: PMC3288760.

So what? Does the test lead to improved health outcomes?

Trevathan E. So what? Does the test lead to improved health outcomes?. Neurology. 2011;77(17):1586-7. DOI: 10.1212/WNL.0b013e3182395d81. PubMed PMID: 21956715.

Perinatal cortical growth and childhood neurocognitive abilities.

Rathbone R, Counsell SJ, Kapellou O, Dyet L, Kennea N, Hajnal J, et al. Perinatal cortical growth and childhood neurocognitive abilities. Neurology. 2011;77(16):1510-7. DOI: 10.1212/WNL.0b013e318233b215. PubMed PMID: 21998316; PubMed Central PMCID: PMC3198973.

Test-retest reliability of Attention Network Test measures in schizophrenia.

Hahn E, Ta TMT, Hahn C, Kuehl LK, Ruehl C, Neuhaus AH, et al. Test-retest reliability of Attention Network Test measures in schizophrenia. Schizophrenia Res. 2011;133(1-3):218-22. DOI: 10.1016/j.schres.2011.09.026. PubMed PMID: 22000937.

"'Timed up and go' test and bone mineral density measurement for fracture prediction.

Zhu K, Devine A, Lewis JR, Dhaliwal SS, Prince RL. "'Timed up and go' test and bone mineral density measurement for fracture prediction. Arch Intern Med. 2011;171(18):1655-61. DOI: 10.1001/archinternmed.2011.434. PubMed PMID: 21987195.

FRAX, falls, and fracture prediction: predicting the future.

Bauer DC. FRAX, falls, and fracture prediction: predicting the future. Arch Intern Med. 2011;171(18):1661-2. DOI: 10.1001/archinternmed.2011.495. PubMed PMID: 21987196.

Continuous epileptiform discharges in patients treated with cefepime or meropenem.

Naeije G, Lorent S, Vincent J-L, Legros B. Continuous epileptiform discharges in patients treated with cefepime or meropenem. Archives Neurology. 2011;68(10):1303-7. DOI: 10.1001/archneurol.2011.204. PubMed PMID: 21987544.

Routine test batteries for cognitive impairment in older people may not be cost effective.

Marks M. Routine test batteries for cognitive impairment in older people may not be cost effective. BMJ. 2011;343:d6330. DOI: 10.1136/bmj.d6330. PubMed PMID: 21971166.